Mário Reis Álvares‐da‐Silva

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients

Mário Reis Álvares‐da‐Silva, Themis Reverbel da Silveira · Nutrition · 2005 · 458 citations

Agriculture, Nutrition, Nutritional Sciences +17

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy et al. · New England Journal of Medicine · 2023 · 263 citations

Medicine, Pharmacology, Pharmacotherapy +17

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease

Juan Pablo Arab, Melisa Dirchwolf, Mário Reis Álvares‐da‐Silva et al. · Annals of Hepatology · 2020 · 139 citations · Full text

Medicine, Endocrinology, Internal Medicine +14

A global research priority agenda to advance public health responses to fatty liver disease

Henry E. Mark, Alina M. Allen, Juan Pablo Arab et al. · Journal of Hepatology · 2023 · 132 citations · Full text

Public Affairs, Health Policy, Epidemiology +12